Transcription of Appendix I Materials for Clinical Applications
{{id}} {{{paragraph}}}
Long-Term Follow-Up Guidelinesfor Survivors of Childhood, Adolescent, and Young Adult CancersVersion 2013 Copyright 2013 Children s Oncology GroupAll rights reserved worldwideAppendix IMaterials for Clinical ApplicationsCOG LTFU Guidelines 8 Page 2 Version October 2013 ContentsContentsReference Materials 3 Abbreviations4 Chemotherapy Agents7 Summary of Cancer Treatment8 Instructions9 Summary Form Template (Abbreviated)11 Summary Form Template (Comprehensive)12 Summary Form Key14 Patient-Specific Guideline Identification Tool23 Instructions24 Patient-Specific Guideline Identification Tool (version )25 Section Number Comparison COG LTFU Guidelines Version vs Reference Guide36 Contents37 Determining Applicability of Radiation Sections for Specific Patients Based on Exposure30 Radiation Dose Calculation Examples39 Radiation Fields Defined40 Radiation Fields by Anatomic Region41 Guideline Radiation Section Numbers by Anatomic Region42 Total Body Irradiation43 Skin, Bones, Soft Tissues44 Brain/Neuroendocrine Axis, Cranium
COG LTFU Guidelines Reference Materials – Page 5 Version 4.0 – October 2013 – Abbreviations Abbreviation Definition Gy Gray HBcAb Hepatitis B core antibody
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
DRUG NAME: Cisplatin, PLATINOL, Pembrolizumab) Injectable Medication Precertification Request, Aetna, HANDLING CYTOTOXIC DRUGS, Drugs With Special Ordering Procedures SAP Chart, AND NECK CANCERS TREATMENT, AND NECK CANCERS TREATMENT REGIMENS Part, Ototoxic Medications, I Materials for Clinical Application of